Velísek L, Velísková J
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Sb Lek. 1994;95(3):161-71.
In this paper we review our data from in vivo and in vitro experiments with mutant, carbonic anhydrase II (CA II) deficient mice (Car2n/Car2n mutants) compared to their nonmutant littermates (Car2n/+ or +/+). In vivo, mutant mice were more resistant to flurothyl-, pentylenetetrazol, and loud sound-induced seizures than normal littermates. The increased resistance to flurothyl seizures was age dependent for clonic seizures, occurring after 19 days of age and disappearing after 90 postnatal days. In in vitro experiments, synaptic transmission in hippocampal slices from mutant mice were more resistant to hypoxia than synaptic transmission in slices from normal littermates. There was almost no difference in hippocampal CA1 long-term potentiation of synaptic transmission between mutants and nonmutants. However, studying in vitro epileptogenesis, we found hippocampal slices from mutants to be more prone to seizures in the low Mg2+ environment than slices from normal littermates. This striking difference between in vivo and in vitro seizures susceptibility in CA II-deficient mutants suggests and existence of an anticonvulsant factor present in conditions in vivo, but not in vitro. We suggest that extracellular proton concentrations (extracellular pH) acting as N-methyl-D-aspartate (NMDA) receptor antagonist may be such a factor. Mutant mice suffer from severe systemic acidosis that can decrease NMDA receptor function and thus be anticonvulsant in vivo. However in vitro, the steady pH of perfusing solution is relatively alkalinic for mutant mouse slices enhancing the thus NMDA receptor conductance and leading to proconvulsant effects. Thus, the anticonvulsant action of CA inhibition in vivo may be mediated by acidotic extracellular pH rather than an accumulation of CO2 as suggested previously.
在本文中,我们回顾了用突变型碳酸酐酶II(CA II)缺陷小鼠(Car2n/Car2n突变体)与其非突变同窝小鼠(Car2n/+或+/+)进行的体内和体外实验数据。在体内,突变小鼠比正常同窝小鼠对氟替尔、戊四氮和大声诱发的癫痫发作更具抵抗力。对氟替尔癫痫发作抵抗力的增加在阵挛性发作方面与年龄有关,在19日龄后出现,出生后90天消失。在体外实验中,突变小鼠海马切片中的突触传递比正常同窝小鼠切片中的突触传递对缺氧更具抵抗力。突变体和非突变体之间海马CA1突触传递的长期增强几乎没有差异。然而,在研究体外癫痫发生时,我们发现突变体的海马切片在低镁环境中比正常同窝小鼠的切片更容易发生癫痫发作。CA II缺陷突变体在体内和体外癫痫易感性之间的这种显著差异表明,体内存在一种抗惊厥因子,而体外不存在。我们认为,作为N-甲基-D-天冬氨酸(NMDA)受体拮抗剂的细胞外质子浓度(细胞外pH值)可能就是这样一种因子。突变小鼠患有严重的全身性酸中毒,这会降低NMDA受体功能,从而在体内起到抗惊厥作用。然而在体外,对于突变小鼠切片,灌注溶液的稳定pH值相对呈碱性,从而增强了NMDA受体电导并导致促惊厥作用。因此,CA抑制在体内的抗惊厥作用可能是由酸性细胞外pH值介导的,而不是如先前所认为的由二氧化碳的积累介导的。